The American Society of Clinical Oncology (ASCO) has raised concerns that utilization management strategies, especially for high-cost prescription drugs, could reduce patient access.
Health plans often experiment with different models to identify optimal strategies on utilization management, especially high-cost prescription drugs. In its new policy statement, the American Society of Clinical Oncology (ASCO) has raised concerns that these strategies could reduce patient access.
Prior authorization (PA), clinical pathways, step-therapy protocols, restrictive formularies, and specialty tiers are some of the ways in which health insurance companies restrict use of prescription drugs. Such restrictions can prove problematic for patients being treated for cancer, because often there is a lack of interchangeable clinical options in oncology. Ensuring compliance with the different health plan policies is also a huge administrative investment for clinics, and to avoid this, ASCO, in collaboration with the American Medical Association, developed resource utilization principles to bring about reform with the process.
“Utilization management strategies, when implemented without appropriate patient safeguards, can impede patient access to high-value, clinically appropriate care,” said ASCO President Daniel F. Hayes, MD, FASCO, FACP. “Payer policies must reflect the current requirements of contemporary cancer care and be evidence-based on what constitutes high-quality care.”
The new policy statement provides the following recommendations:
The policy statment recommends following ASCO’s criteria, “which promote patient protections for clinical pathway development, implementation and use, and analytics.”
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
IQVIA Report Spotlights Shortages for Pain, Obesity, and Oncology Therapies
November 21st 2023A new report from IQVIA provides an overview of current US drug shortages, shedding light on major areas of concern, such as medications to address pain, cardiovascular conditions, obesity and diabetes, and multiple forms of cancer.
Read More